Diagnostic Value of F-18 FDG PET/CT in Patients with Spondylodiscitis: Is Dual Time Point Imaging Time Worthy?
Overview
Microbiology
Pathology
Authors
Affiliations
Purpose: In this retrospective study, we aimed to investigate the value of FDG-PET/CT in the diagnosis of spondylodiscitis (SD), the significance of dual time point imaging (DTPI) for SD diagnosis and the worth of SUVmax data for distinguishing tuberculous vs. non-tuberculous SD.
Materials And Methods: 32 patients with suspected SD were scanned with FDG-PET/CT. For quantitative analysis maximum standardized uptake value (SUVmax) of the lesion area was measured. Nineteen patients had DTPI of FDG-PET/CT. The final diagnoses were achieved by histopathological, microbiological, and clinical results.
Results: Specific pathogens were isolated in 21 patients; other patients were accepted as nonspecific bacterial SD. In all patients, FDG-PET/CT results were compatible with SD diagnosis. The SUVmax data for tuberculous and non-tuberculous SD and DTPI results were statistically insignificant.
Conclusion: FDG-PET/CT is a successful modality for SD diagnosis; additionally, DTPI protocol for FDG-PET/CT in SD diagnosis and SUVmax data for differentiation between non-tbc SD and tbc SD are useless.
Zhu W, Zhou S, Zhang J, Li L, Liu P, Xiong W Med Sci Monit. 2024; 30:e943168.
PMID: 38555491 PMC: 10989196. DOI: 10.12659/MSM.943168.
Boriani L, Zamparini E, Albrizio M, Serani F, Ciani G, Marconi L Curr Med Imaging. 2021; 18(2):216-230.
PMID: 34530718 PMC: 9241079. DOI: 10.2174/1573405617666210916121046.
Casali M, Lauri C, Altini C, Bertagna F, Cassarino G, Cistaro A Clin Transl Imaging. 2021; 9(4):299-339.
PMID: 34277510 PMC: 8271312. DOI: 10.1007/s40336-021-00445-w.
Incremental value of FDG-PET/CT to monitor treatment response in infectious spondylodiscitis.
Righi E, Carnelutti A, Muser D, Di Gregorio F, Cadeo B, Melchioretto G Skeletal Radiol. 2020; 49(6):903-912.
PMID: 31900514 DOI: 10.1007/s00256-019-03328-4.
Treglia G, Pascale M, Lazzeri E, van der Bruggen W, Delgado Bolton R, Glaudemans A Eur J Nucl Med Mol Imaging. 2019; 47(5):1287-1301.
PMID: 31729539 DOI: 10.1007/s00259-019-04571-6.